Amaero International's proposal and recent developments

Amaero International Limited (ASX: $3DA) has proposed the issuance of 60,606,061 fully paid ordinary shares to eligible institutional investors as part of the Placement. Additionally, the company has entered into a binding offtake agreement for the supply of C103 AM powder and successfully raised $20 million through an institutional placement at a fixed price of $0.33 per new share.

Hank Holland, Amaero's Chairman and CEO, on the recent developments

This is a very important milestone for Amaero. Amaero aspires to be the largest U.S. domestic producer of C103 and specialty alloy AM powders and to be the most responsive, agile producer. In order for additive manufacturing to achieve its potential, it's imperative that we stand up an alternative U.S. domestic supplier of C103 and specialty AM powder. Time is of the essence. There must be a sense of urgency to collaborate with and to assist DoD-funded laboratories and prime defence contractors to advance hypersonic and strategic missile programs from the development and demonstration phase to the production phase. The alignment and collaboration will be an important development for demonstrating manufacturing readiness and for advancing the insertion of additive manufacturing into the most strategic and most critical defence and space applications.

Summary of Amaero International's recent proposal and developments

Amaero International Limited (ASX: $3DA) has proposed the issuance of 60,606,061 fully paid ordinary shares to eligible institutional investors and entered into a binding offtake agreement for the supply of C103 AM powder. The company has successfully raised $20 million through an institutional placement at a fixed price of $0.33 per new share. Amaero's Chairman and CEO, Hank Holland, expressed the company's aspirations to become the largest U.S. domestic producer of C103 and specialty alloy AM powders and emphasized the importance of collaboration with DoD-funded laboratories and prime defence contractors to advance hypersonic and strategic missile programs. The company expects to use the proceeds of the placement for general corporate purposes, including working capital, operating expenses, and capital expenditures.